30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Olagunju Peter

Insider profile

Olagunju Peter's trades of TCR2 Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-12-13 2022-12-13 PlS Planned sale
69,533 +46.5%
202.84
US$2,760,988
69,533 +46.5% 202.84 US$2,760,988
2022-12-13 2022-12-12 PlS Planned sale
73,177 -44.8%
393.33
US$1,473,490
73,177 -44.8% 393.33 US$1,473,490
2022-12-13 2022-12-09 PlS Planned sale
97,751 +40.9%
344.54
US$1,051,199
97,751 +40.9% 344.54 US$1,051,199
2022-12-09 2022-12-08 PlS Planned sale
1,410 -4.6%
1.25
US$1,767
1,410 -4.6% 1.25 US$1,767
2022-12-09 2022-12-07 PlS Planned sale
1,378 -4.3%
1.28
US$1,767
1,378 -4.3% 1.28 US$1,767
2022-12-07 2022-12-06 PlS Planned sale
1,327 -4.0%
1.33
US$1,765
1,327 -4.0% 1.33 US$1,765
2022-12-07 2022-12-05 PlS Planned sale
1,291 -3.8%
1.37
US$1,766
1,291 -3.8% 1.37 US$1,766
2022-12-05 2022-12-02 PlS Planned sale
1,273 -3.6%
1.39
US$1,766
1,273 -3.6% 1.39 US$1,766